Notify me when Roy T. Eddleman files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RGEN | Repligen Corporation. | Common Stock, $.01 par value per share | 4.84% | $377M | 2.71M | Roy T. Eddleman Living Trust | Dec 31, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|